MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • ‘That dark place’ – A thematic exploration of why people with Parkinson’s living in the UK, may, at times, experience suicidal ideation, as conveyed through an internet Forum

    E. Edwards (Plymouth, United Kingdom)

  • “Grab-the-lock test “ – A novel clinical test for identification of dorsolateral Subthalamic nucleus [STN] during deep brain stimulation [DBS]

    A. Panwar, N. Sawal, M. Matta (SAS Nagar, India)

  • “Speaking aids in neurodegenerative ataxia: how to deal with own disability”

    C. Fernandes, I. Cunha, C. Gouveia, C. Rodrigues, F. Matias (Coimbra, Portugal)

  • 10 year longitudinal change in clinical and biological characteristics of sporadic Parkinson Disease PPMI cohort

    P. Gonzalez-Latapi, T. Simuni, A. Siderowf, J. Fedler, M. Brumm, C. Gochanour, C. Coffey, K. Marek (Chicago, USA)

  • 15-year effects of initiating treatment for Parkinson’s disease with dopamine agonists or monoamine oxidase B inhibitors compared with levodopa: final results of PD MED early disease randomisation

    C. Clarke, C. Rick, S. Patel, R. Wooley, N. Rowland, J. Futterer, R. Ottridge, C. Jenkinson, R. Gray (Birmingham, United Kingdom)

  • 18F-Florzolotau PET Imaging Captures the Distribution Patterns and Regional Vulnerability of Tau Pathology in Progressive Supranuclear Palsy

    FT. Liu, JY. Lu, XY. Li, YM. Sun, JJ. Wu, TC. Yen, QH. Zhao, CT. Zuo, J. Wang (Shanghai, China)

  • 18F-Florzolotau PET imaging of tau pathology in the living brain of patients with corticobasal syndrome

    FT. Liu, JY. Lu, XY. Li, YM. Sun, JJ. Wu, TC. Yen, QH. Zhao, CT. Zuo, J. Wang (Shanghai, China)

  • 18f-PI-2620 tau PET neuroimaging, tau protein burden and 18f-PI-2620 tau autoradiography on human postmortem brain tissue in a PSP patient

    ME. Erro, G. Martí-Andrés, A. Bronte, C. Caballero, J. Sánchez, E. Pérez-Martínez, S. Bullich, A. Mueller, MR. Luquin, J. Arbizu (Pamplona, Spain)

  • 24(S)-Hydroxycholesterol and cognition in Huntington’s disease: results from two large patient cohorts (TRACK-HD and ENROLL-HD)

    S. Gray, M. Lewis, T. Kazdoba, A. Koenig, E. Lefler, K. Paumier, M. Quirk, J. Doherty (Cambridge, USA)

  • 3D Multi-Delay pCASL to Understand Perfusion Changes in Patients with Parkinson’s disease with Mild Cognitive Impairment

    B. Thomas, Z. Mari, V. Mishra (Dallas, USA)

  • 1
  • 2
  • 3
  • …
  • 186
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley